TY - JOUR
T1 - The premenopausal breast cancer collaboration
T2 - A pooling project of studies participating in the national cancer institute cohort consortium
AU - Nichols, Hazel B.
AU - Schoemaker, Minouk J.
AU - Wright, Lauren B.
AU - McGowan, Craig
AU - Brook, Mark N.
AU - Mcclain, Kathleen M.
AU - Jones, Michael E
AU - Adami, Hans-Olov
AU - Agnoli, Claudia
AU - Baglietto, Laura
AU - Bernstein, Leslie
AU - Bertrand, Kimberly A
AU - Blot, William J.
AU - Boutron-Ruault, Marie Christine
AU - Butler, Lesley M
AU - Chen, Kuan-Yu
AU - Doody, Michele M.
AU - Dossus, Laure
AU - Eliassen, A. Heather
AU - Giles, Graham G.
AU - Gram, Inger T.
AU - Hankinson, Susan E.
AU - Hoffman-Bolton, Judy
AU - Kaaks, Rudolf
AU - Key, Timothy J.
AU - Kirsh, Victoria A.
AU - Kitahara, Cari M
AU - Koh, Woon-Puay
AU - Larsson, Susanna C.
AU - Lund, Eiliv
AU - Ma, Huiyan
AU - Merritt, Melissa A.
AU - Milne, Roger L.
AU - Navarro, Carmen
AU - Overvad, Kim
AU - Ozasa, Kotaro
AU - Palmer, Julie R.
AU - Peeters, Petra H.
AU - Riboli, Elio
AU - Rohan, Thomas E.
AU - Sadakane, Atsuko
AU - Sund, Malin
AU - Tamimi, Rulla M
AU - Trichopoulou, Antonia
AU - Vatten, Lars
AU - Visvanathan, Kala
AU - Weiderpass, Elisabete
AU - Willett, Walter C.
AU - Wolk, Alicja
AU - Zeleniuch-Jacquotte, Anne
AU - Zheng, Wei
AU - Sandler, Dale P
AU - Swerdlow, Anthony J.
N1 - Funding Information:
Support for this research comes, in part, from the Avon Foundation (02-2014-080); Breast Cancer Now; The Institute of Cancer Research, London; the United States National Institutes of Health National Institute of Environmental Health Sciences (Z01 ES044005, P30 ES000260) and National Cancer Institute (UM1 CA176726, UM1 CA186107, UM1 CA182876, UM1 CA182934, UM1 CA164974, R01 CA058420, R01 CA092447, CA077398, CA144034); the United States National Center for Advancing Translational Sciences (KL2-TR001109), the National Program of Cancer Registries of the Centers for Disease Control and Prevention, and the Department of Energy; the Swedish Research Council and Swedish Cancer Foundation; the Japanese Ministry of Health, Labor and Welfare; the Hellenic Health Foundation; Karolinska Insti-tutet Distinguished Professor Award Dnr: 2368/10-221; Cancer Council Victoria and the Australia National Health and Medical Research Council (209057, 396414, 504711); the State of Maryland, the Maryland Cigarette Restitution Fund; and the United Kingdom National Health Service funding to the Royal Marsden/ICR NIHR Biomedical Research Centre. The coordination of the European Prospective Investigation in Cancer is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santéet de la Recherche Médicale (INSERM; France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence program on Food, Nutrition and Health (Norway); Health Research Fund (FIS), PI13/00061 to Granada, PI13/01162 to EPIC-Murcia, Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020; Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Ska°ne and V€asterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford; United Kingdom).
Publisher Copyright:
© 2017 American Association for Cancer Research.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Breast cancer is a leading cancer diagnosis among premenopausal women around the world. Unlike rates in postmenopausal women, incidence rates of advanced breast cancer have increased in recent decades for premenopausal women. Progress in identifying contributors to breast cancer risk among premenopausal women has been constrained by the limited numbers of premenopausal breast cancer cases in individual studies and resulting low statistical power to subcategorize exposures or to study specific subtypes. The Premenopausal Breast Cancer Collaborative Group was established to facilitate cohort-based analyses of risk factors for premenopausal breast cancer by pooling individuallevel data from studies participating in the United States National Cancer Institute Cohort Consortium. This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations.
AB - Breast cancer is a leading cancer diagnosis among premenopausal women around the world. Unlike rates in postmenopausal women, incidence rates of advanced breast cancer have increased in recent decades for premenopausal women. Progress in identifying contributors to breast cancer risk among premenopausal women has been constrained by the limited numbers of premenopausal breast cancer cases in individual studies and resulting low statistical power to subcategorize exposures or to study specific subtypes. The Premenopausal Breast Cancer Collaborative Group was established to facilitate cohort-based analyses of risk factors for premenopausal breast cancer by pooling individuallevel data from studies participating in the United States National Cancer Institute Cohort Consortium. This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations.
UR - http://www.scopus.com/inward/record.url?scp=85028922188&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-17-0246
DO - 10.1158/1055-9965.EPI-17-0246
M3 - Review article
C2 - 28600297
AN - SCOPUS:85028922188
SN - 1055-9965
VL - 26
SP - 1360
EP - 1369
JO - Cancer Epidemiology Biomarkers & Prevention
JF - Cancer Epidemiology Biomarkers & Prevention
IS - 9
ER -